Annual D&A
$23.45 M
+$5.42 M+30.05%
31 December 2023
Summary:
Organogenesis Holdings annual depreciation & amortization is currently $23.45 million, with the most recent change of +$5.42 million (+30.05%) on 31 December 2023. During the last 3 years, it has risen by +$15.27 million (+186.56%). ORGO annual D&A is now at all-time high.ORGO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$4.40 M
+$204.00 K+4.86%
30 September 2024
Summary:
Organogenesis Holdings quarterly depreciation & amortization is currently $4.40 million, with the most recent change of +$204.00 thousand (+4.86%) on 30 September 2024. Over the past year, it has increased by +$631.00 thousand (+16.72%). ORGO quarterly D&A is now -64.18% below its all-time high of $12.29 million, reached on 31 December 2023.ORGO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$24.87 M
+$631.00 K+2.60%
30 September 2024
Summary:
Organogenesis Holdings TTM depreciation & amortization is currently $24.87 million, with the most recent change of +$631.00 thousand (+2.60%) on 30 September 2024. Over the past year, it has increased by +$3.68 million (+17.37%). ORGO TTM D&A is now at all-time high.ORGO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORGO Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +30.1% | +16.7% | +17.4% |
3 y3 years | +186.6% | -6.9% | +74.8% |
5 y5 years | +236.0% | +89.8% | +186.0% |
ORGO Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +186.6% | -64.2% | +71.5% | at high | +94.1% |
5 y | 5 years | at high | +236.0% | -64.2% | +158.0% | at high | +203.9% |
alltime | all time | at high | +316.6% | -64.2% | +172.2% | at high | +1290.3% |
Organogenesis Holdings Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $4.40 M(+4.9%) | $24.87 M(+2.6%) |
June 2024 | - | $4.20 M(+5.7%) | $24.24 M(+3.2%) |
Mar 2024 | - | $3.97 M(-67.7%) | $23.50 M(+0.2%) |
Dec 2023 | $23.45 M(+30.0%) | $12.29 M(+225.9%) | $23.45 M(+10.7%) |
Sept 2023 | - | $3.77 M(+9.1%) | $21.19 M(+5.5%) |
June 2023 | - | $3.46 M(-11.9%) | $20.09 M(+3.7%) |
Mar 2023 | - | $3.92 M(-60.9%) | $19.39 M(+7.5%) |
Dec 2022 | $18.03 M(+8.1%) | $10.04 M(+275.1%) | $18.03 M(+40.7%) |
Sept 2022 | - | $2.68 M(-2.7%) | $12.82 M(-13.8%) |
June 2022 | - | $2.75 M(+7.0%) | $14.87 M(-6.2%) |
Mar 2022 | - | $2.57 M(-46.8%) | $15.86 M(-4.9%) |
Dec 2021 | $16.68 M | $4.82 M(+1.9%) | $16.68 M(+17.2%) |
Sept 2021 | - | $4.73 M(+26.6%) | $14.23 M(+19.8%) |
June 2021 | - | $3.74 M(+10.6%) | $11.88 M(+20.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | $3.38 M(+42.1%) | $9.85 M(+20.3%) |
Dec 2020 | $8.18 M(-16.7%) | $2.38 M(+0.1%) | $8.18 M(-4.3%) |
Sept 2020 | - | $2.38 M(+39.3%) | $8.55 M(+0.7%) |
June 2020 | - | $1.71 M(-0.7%) | $8.49 M(-7.1%) |
Mar 2020 | - | $1.72 M(-37.4%) | $9.14 M(-6.9%) |
Dec 2019 | $9.83 M(+40.8%) | $2.75 M(+18.4%) | $9.83 M(+13.0%) |
Sept 2019 | - | $2.32 M(-1.6%) | $8.70 M(+6.6%) |
June 2019 | - | $2.36 M(-1.8%) | $8.15 M(+7.5%) |
Mar 2019 | - | $2.40 M(+48.3%) | $7.59 M(+8.8%) |
Dec 2018 | $6.98 M(+24.0%) | $1.62 M(-9.1%) | $6.98 M(+30.2%) |
Sept 2018 | - | $1.78 M(-0.7%) | $5.36 M(+49.7%) |
June 2018 | - | $1.79 M(+0.2%) | $3.58 M(+100.2%) |
Mar 2018 | - | $1.79 M | $1.79 M |
Dec 2017 | $5.63 M(-23.1%) | - | - |
Dec 2016 | $7.32 M | - | - |
FAQ
- What is Organogenesis Holdings annual depreciation & amortization?
- What is the all time high annual D&A for Organogenesis Holdings?
- What is Organogenesis Holdings annual D&A year-on-year change?
- What is Organogenesis Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly D&A year-on-year change?
- What is Organogenesis Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for Organogenesis Holdings?
- What is Organogenesis Holdings TTM D&A year-on-year change?
What is Organogenesis Holdings annual depreciation & amortization?
The current annual D&A of ORGO is $23.45 M
What is the all time high annual D&A for Organogenesis Holdings?
Organogenesis Holdings all-time high annual depreciation & amortization is $23.45 M
What is Organogenesis Holdings annual D&A year-on-year change?
Over the past year, ORGO annual depreciation & amortization has changed by +$5.42 M (+30.05%)
What is Organogenesis Holdings quarterly depreciation & amortization?
The current quarterly D&A of ORGO is $4.40 M
What is the all time high quarterly D&A for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly depreciation & amortization is $12.29 M
What is Organogenesis Holdings quarterly D&A year-on-year change?
Over the past year, ORGO quarterly depreciation & amortization has changed by +$631.00 K (+16.72%)
What is Organogenesis Holdings TTM depreciation & amortization?
The current TTM D&A of ORGO is $24.87 M
What is the all time high TTM D&A for Organogenesis Holdings?
Organogenesis Holdings all-time high TTM depreciation & amortization is $24.87 M
What is Organogenesis Holdings TTM D&A year-on-year change?
Over the past year, ORGO TTM depreciation & amortization has changed by +$3.68 M (+17.37%)